JP2019081762A5 - - Google Patents

Download PDF

Info

Publication number
JP2019081762A5
JP2019081762A5 JP2018238486A JP2018238486A JP2019081762A5 JP 2019081762 A5 JP2019081762 A5 JP 2019081762A5 JP 2018238486 A JP2018238486 A JP 2018238486A JP 2018238486 A JP2018238486 A JP 2018238486A JP 2019081762 A5 JP2019081762 A5 JP 2019081762A5
Authority
JP
Japan
Prior art keywords
alkyl
fluoroalkyl
cycloalkyl
alkoxy
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018238486A
Other languages
English (en)
Japanese (ja)
Other versions
JP6632701B2 (ja
JP2019081762A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019081762A publication Critical patent/JP2019081762A/ja
Publication of JP2019081762A5 publication Critical patent/JP2019081762A5/ja
Application granted granted Critical
Publication of JP6632701B2 publication Critical patent/JP6632701B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018238486A 2012-10-12 2018-12-20 ベンズアミド Expired - Fee Related JP6632701B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261713113P 2012-10-12 2012-10-12
US61/713,113 2012-10-12

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015536142A Division JP6515409B2 (ja) 2012-10-12 2013-10-11 ベンズアミド

Publications (3)

Publication Number Publication Date
JP2019081762A JP2019081762A (ja) 2019-05-30
JP2019081762A5 true JP2019081762A5 (https=) 2019-07-04
JP6632701B2 JP6632701B2 (ja) 2020-01-22

Family

ID=49551580

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015536142A Expired - Fee Related JP6515409B2 (ja) 2012-10-12 2013-10-11 ベンズアミド
JP2018238486A Expired - Fee Related JP6632701B2 (ja) 2012-10-12 2018-12-20 ベンズアミド

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015536142A Expired - Fee Related JP6515409B2 (ja) 2012-10-12 2013-10-11 ベンズアミド

Country Status (42)

Country Link
US (4) US9102591B2 (https=)
EP (1) EP2906546B1 (https=)
JP (2) JP6515409B2 (https=)
KR (1) KR20150067188A (https=)
CN (1) CN104884445B (https=)
AP (1) AP2015008406A0 (https=)
AR (1) AR092973A1 (https=)
AU (1) AU2013328584B2 (https=)
BR (1) BR112015008117A2 (https=)
CA (1) CA2887096C (https=)
CL (1) CL2015000902A1 (https=)
CR (1) CR20150171A (https=)
CY (1) CY1120008T1 (https=)
DK (1) DK2906546T3 (https=)
DO (1) DOP2015000076A (https=)
EA (1) EA026396B1 (https=)
EC (1) ECSP15013883A (https=)
ES (1) ES2662523T3 (https=)
GE (1) GEP201706621B (https=)
HR (1) HRP20180272T1 (https=)
HU (1) HUE038223T2 (https=)
IL (1) IL237914A0 (https=)
LT (1) LT2906546T (https=)
MA (1) MA37990B1 (https=)
ME (1) ME02982B (https=)
MX (1) MX369717B (https=)
NI (1) NI201500050A (https=)
NO (1) NO2851818T3 (https=)
NZ (1) NZ630830A (https=)
PE (1) PE20150709A1 (https=)
PH (1) PH12015500746B1 (https=)
PL (1) PL2906546T3 (https=)
PT (1) PT2906546T (https=)
RS (1) RS56925B1 (https=)
RU (1) RU2015113320A (https=)
SG (1) SG11201502680QA (https=)
SI (1) SI2906546T1 (https=)
SM (1) SMT201800136T1 (https=)
TN (1) TN2015000107A1 (https=)
TR (1) TR201802992T4 (https=)
TW (1) TWI598325B (https=)
WO (1) WO2014057078A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI598325B (zh) * 2012-10-12 2017-09-11 H 朗德貝克公司 苯甲醯胺類
TW201427947A (zh) 2012-10-12 2014-07-16 Lundbeck & Co As H 環狀胺
WO2014091415A1 (en) 2012-12-12 2014-06-19 Actelion Pharmaceuticals Ltd Indole carboxamide derivatives as p2x7 receptor antagonists
KR102232744B1 (ko) 2012-12-18 2021-03-26 이도르시아 파마슈티컬스 리미티드 P2x7 수용체 길항제로서의 인돌 카르복사미드 유도체
ES2616883T3 (es) 2013-01-22 2017-06-14 Actelion Pharmaceuticals Ltd. Derivados amida heterocíclicos como antagonistas del receptor P2X7
CA2896790C (en) 2013-01-22 2022-05-10 Actelion Pharmaceuticals Ltd Heterocyclic amide derivatives as p2x7 receptor antagonists
CN105503787A (zh) * 2015-12-31 2016-04-20 阜阳欣奕华材料科技有限公司 一种索非布韦中间体的纯化方法
CN106366056B (zh) * 2016-08-26 2018-12-11 常州市阳光药业有限公司 3-氨甲基四氢呋喃的制备方法
ES2963044T3 (es) * 2017-03-13 2024-03-25 Raqualia Pharma Inc Derivados de tetrahidroquinolina como antagonistas del receptor P2X7
BR112020018094A2 (pt) 2018-03-08 2020-12-22 Incyte Corporation Compostos de aminopirazina diol como inibidores de pi3k-¿
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
WO2020227159A2 (en) 2019-05-03 2020-11-12 Flagship Pioneering Innovations V, Inc. Methods of modulating immune activity
CN117088878A (zh) * 2020-10-28 2023-11-21 杭州阿诺生物医药科技有限公司 一种高活性Wnt通路抑制剂化合物
CA3226468A1 (en) * 2021-08-02 2023-02-09 Andrew Edmunds Microbiocidal pyrazole derivatives

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1445707A1 (de) 1962-05-05 1969-03-13 Hoechst Ag Piperidinverbindungen und Verfahren zu ihrer Herstellung
US3435038A (en) * 1965-06-01 1969-03-25 Sandoz Ag 5,6,7,9,10,14b-hexahydroisoquinolo (2,1-d) benzo (1,4) diazepines
US6632836B1 (en) * 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
US6194458B1 (en) 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
US6303637B1 (en) * 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors
SE0003476D0 (sv) * 2000-09-28 2000-09-28 Astrazeneca Ab Compounds
TW200300083A (en) 2001-11-12 2003-05-16 Pfizer Prod Inc Benzamide, heteroarylamide and reverse amides
PA8557501A1 (es) * 2001-11-12 2003-06-30 Pfizer Prod Inc Benzamida, heteroarilamida y amidas inversas
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
PA8591801A1 (es) 2002-12-31 2004-07-26 Pfizer Prod Inc Inhibidores benzamidicos del receptor p2x7.
ATE355273T1 (de) * 2003-05-12 2006-03-15 Pfizer Prod Inc Benzamidinhibitoren des p2x7-rezeptors
EP1673357A2 (en) 2003-08-08 2006-06-28 Vertex Pharmaceuticals Incorporated Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
TWI368482B (en) 2003-12-19 2012-07-21 Bayer Sas New 2-pyridinylethylbenzamide derivatives
AU2005228133B2 (en) 2004-03-24 2011-09-08 Merck Sharp & Dohme Corp. Heteroaryl piperidine glycine transporter inhibitors
EP1763353A1 (en) * 2004-06-29 2007-03-21 Warner-Lambert Company LLC COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR
WO2006067529A1 (en) * 2004-12-21 2006-06-29 Merck Sharp & Dohme Limited Piperidine and azetidine derivatives as glyt1 inhibitors
WO2006080884A1 (en) * 2005-01-27 2006-08-03 Astrazeneca Ab Novel biaromatic compounds, inhibitors of the p2x7-receptor
AU2006258842B2 (en) * 2005-06-13 2011-09-15 Merck Sharp & Dohme Limited Therapeutic agents
CA2625039A1 (en) 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
JP2009057282A (ja) 2005-12-19 2009-03-19 Astellas Pharma Inc カルボン酸誘導体又はその塩
TWI435863B (zh) 2006-03-20 2014-05-01 Nihon Nohyaku Co Ltd N-2-(雜)芳基乙基甲醯胺衍生物及含該衍生物之蟲害防治劑
WO2009003672A2 (en) * 2007-07-02 2009-01-08 Syngenta Participations Ag Novel microbiocides
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
KR101598397B1 (ko) * 2008-04-22 2016-02-29 얀센 파마슈티카 엔.브이. 퀴놀린 또는 이소퀴놀린 치환된 피2엑스7 안타고니스트
ES2345527B1 (es) * 2008-10-08 2011-09-08 Hospital Clinic I Provincial De Barcelona Sustancias bloqueadoras de los canales kv 1.3 para el tratamiento de enfermedades asociadas a hiperplasia de la intima.
JP2013532185A (ja) 2010-07-12 2013-08-15 ファイザー・リミテッド 化合物
AU2012224015B2 (en) * 2011-03-02 2017-04-13 Nihon Nohyaku Co., Ltd. Internal parasiticide
EP2773203A1 (en) * 2011-11-02 2014-09-10 Bayer Intellectual Property GmbH Compounds with nematicidal activity
MX349802B (es) * 2011-11-25 2017-08-14 Bayer Ip Gmbh Uso de aril- y hetarilcarboxamidas como endoparasiticidas.
TWI598325B (zh) * 2012-10-12 2017-09-11 H 朗德貝克公司 苯甲醯胺類
TW201427947A (zh) * 2012-10-12 2014-07-16 Lundbeck & Co As H 環狀胺

Similar Documents

Publication Publication Date Title
JP2019081762A5 (https=)
HRP20210949T1 (hr) Spojevi i sastavi za moduliranje aktivnosti egfr mutant kinaze
JP2016534134A5 (https=)
JP2017502940A5 (https=)
JP2018507877A5 (https=)
JP2016523955A5 (https=)
JP2017537949A5 (https=)
JP2014506907A5 (https=)
RU2015113320A (ru) Бензамиды
JP2019509291A5 (https=)
PE20180227A1 (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
HRP20251220T1 (hr) Derivati bipirazola kao jak inhibitori
JP2015504081A5 (https=)
JP2016536364A5 (https=)
JP2017511794A5 (https=)
RU2015151502A (ru) Химические соединения
AR074426A1 (es) Compuesto de n-(((1s,4s,6s)-3-(2-piridinilcarbonil)3-azabiciclo (4,1.0)hept-4-il) metil)-2-heteroarilamina, su uso para la prepracion de un medicamento para el tratamiento de una enfermedad que requiere un antagonista de un receptor de orexina humana y composicion farmaceutica que lo comprende
JP2017504635A5 (https=)
JP2014507455A5 (https=)
JP2016519165A5 (https=)
JP2014139226A5 (https=)
WO2012007869A3 (en) N- sulfonylbenzamides as inhibitors of voltage - gated sodium channels
HRP20170638T1 (hr) MODULATORI RETINOIDNIMA SRODNOG SIROČETA RECEPTORA γ (ROR-γ), NAMIJENJENI UPOTREBI U LIJEČENJU AUTOIMUNIH I PROTUUPALNIH BOLESTI
JP2012530705A5 (https=)
HRP20161177T1 (hr) Modulator glukagonskog receptora